IDEXX Laboratories, Inc. (LON: 0J8P)

London flag London · Delayed Price · Currency is GBP · Price in USD
417.29
+4.71 (1.14%)
Dec 20, 2024, 4:55 PM BST
-23.46%
Market Cap 26.85B
Revenue (ttm) 2.87B
Net Income (ttm) 646.30M
Shares Out n/a
EPS (ttm) 7.73
PE Ratio 41.55
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 147
Open 406.78
Previous Close 412.59
Day's Range 405.25 - 417.29
52-Week Range 373.77 - 583.30
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 3, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnos... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1983
Employees 11,000
Stock Exchange London Stock Exchange
Ticker Symbol 0J8P
Full Company Profile

Financial Performance

In 2023, IDEXX Laboratories's revenue was $3.66 billion, an increase of 8.72% compared to the previous year's $3.37 billion. Earnings were $845.04 million, an increase of 24.44%.

Financial numbers in USD Financial Statements

News

SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX

Sustainability Roundtable Inc. announced Synopsys, IDEXX, and Juniper Networks as winners of the 2024 SBER Awards for standout leadership in sustainability

3 days ago - GlobeNewsWire

Why Investors Are Eyeing IDEXX Laboratories Inc (IDXX): The Key Drivers of Market ...

Why Investors Are Eyeing IDEXX Laboratories Inc (IDXX): The Key Drivers of Market Outperformance and Growth Potential

12 days ago - GuruFocus

IDEXX Laboratories (IDXX) Expands Share Repurchase Program

IDEXX Laboratories (IDXX) Expands Share Repurchase Program

13 days ago - GuruFocus

IDEXX Laboratories Inc (IDXX) Expands Share Repurchase Program

IDEXX Laboratories Inc (IDXX) Expands Share Repurchase Program

14 days ago - GuruFocus

IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that the Company's Board of Directors authorized an increase i...

14 days ago - Business Wire

Insider Sell: Sophie Vandebroek Sells Shares of IDEXX Laboratories Inc (IDXX)

Insider Sell: Sophie Vandebroek Sells Shares of IDEXX Laboratories Inc (IDXX)

23 days ago - GuruFocus

Executive reshuffles: MFC, LYB, IDXX and TEX

Recent management changes in various companies include retirements and new appointments in key executive roles, impacting their growth prospects.

4 weeks ago - Seeking Alpha

IDEXX Laboratories (IDXX) Announces CFO Transition

IDEXX Laboratories (IDXX) Announces CFO Transition

4 weeks ago - GuruFocus

IDEXX Announces CFO Transition

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon has decided to retire from IDEXX effective J...

4 weeks ago - Business Wire

ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents

DENVER--(BUSINESS WIRE)--The American College of Veterinary Internal Medicine (ACVIM) is excited to announce a new endorsement partnership with IDEXX Laboratories, Inc., of complimentary resident-focu...

5 weeks ago - Business Wire

IDEXX Laboratories Q3: Weak End-Market Demand Continues

I reiterate a 'Sell' rating on IDEXX due to weak U.S. clinical visits and demand, with a one-year price target of $400 per share. IDEXX's Q3 results showed a 2.1% decline in same-store clinical visits...

6 weeks ago - Seeking Alpha

IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - President and CEO Conference Call Participan...

7 weeks ago - Seeking Alpha

CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--In the 2024 Growth and Financial Performance Outlook section, second paragraph, second sentence should read: At midpoint, projected full year comparable operating pr...

7 weeks ago - Business Wire

Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth

Idexx Laboratories Inc IDXX reported third-quarter adjusted EPS of $2.79, up 12% year-over-year, beating the consensus of $2.68.

7 weeks ago - Benzinga

IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow

IDEXX Laboratories trimmed its annual revenue forecast for the third time on Thursday, as the animal health diagnostic equipment maker sees fewer visits to veterinary clinics from pet owners.

7 weeks ago - Reuters

IDEXX Laboratories Announces Third Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company repor...

7 weeks ago - Business Wire

IDEXX Laboratories to Release 2024 Third Quarter Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 third quarter results for Thursday, Octo...

2 months ago - Business Wire

IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and ...

4 months ago - Business Wire

IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits

IDEXX reported lower full-year organic revenue growth due to reduced U.S. clinical visits. Weak consumer sentiment and ongoing staffing challenges may continue to impact clinical visits in the near fu...

4 months ago - Seeking Alpha

Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst

Tuesday, Idexx Laboratories Inc IDXX reported second-quarter adjusted EPS of $3.02, up 15% year-over-year, beating the consensus of $2.88.

4 months ago - Benzinga

IDEXX Laboratories, Inc. (IDXX) Q2 2024 Earnings Call Transcript

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - President and CEO Conference Call Participants...

4 months ago - Seeking Alpha

IDEXX Laboratories Announces Second Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results. Second Quarter Results The Company rep...

4 months ago - Business Wire

The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data

This marks the last peak week of the Q2 earnings season with 3,908 companies expected to report. Earnings have come in better-than-expected, but tend to be overshadowed by economic data. Outlier earni...

4 months ago - Seeking Alpha

IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will now host its 2024 second quarter conference call and webcast at 9:00 am E...

5 months ago - Business Wire